Literature DB >> 7763113

Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.

Y Fujikawa1, M Shingu, T Torisu, S Masumi.   

Abstract

OBJECTIVE: To measure the amounts of interleukin-1 receptor antagonist (IL-1ra) protein produced by cultured synovial cells obtained from patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
METHODS: Synovial cells obtained from patients with either RA or OA were cultured and the supernatants were measured for IL-1ra by enzyme linked immunosorbent assay.
RESULTS: The synovial cells obtained from patients with RA produced significantly smaller amounts of IL-1ra than did those obtained from patients with OA, in a late passage (third to fifth) without stimulation and a first passage both with and without stimulation (p < 0.025, respectively). In addition, when the patients with RA were divided into two groups according to the maximum number of lining cell layers, the amounts of IL-1ra produced by the proliferative type were smaller than those produced by the less proliferative type (p < 0.025).
CONCLUSIONS: The above findings suggest that IL-1ra production in RA synovial cells is suppressed, and that reduced IL-1ra protein production is one of the causes which leads to the proliferation of lining cells and persistent joint inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763113      PMCID: PMC1005582          DOI: 10.1136/ard.54.4.318

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

Review 2.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

4.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

Authors:  J M Dayer; B de Rochemonteix; B Burrus; S Demczuk; C A Dinarello
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

8.  Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness.

Authors:  R J Smith; J E Chin; L M Sam; J M Justen
Journal:  Arthritis Rheum       Date:  1991-01

9.  Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils.

Authors:  M Malyak; R E Swaney; W P Arend
Journal:  Arthritis Rheum       Date:  1993-06

10.  Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs.

Authors:  B Haraoui; J P Pelletier; J M Cloutier; M P Faure; J Martel-Pelletier
Journal:  Arthritis Rheum       Date:  1991-02
View more
  5 in total

Review 1.  The role of synovitis in osteoarthritis pathogenesis.

Authors:  Carla R Scanzello; Steven R Goldring
Journal:  Bone       Date:  2012-02-22       Impact factor: 4.398

2.  Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis.

Authors:  L Gramantieri; A Casali; D Trerè; S Gaiani; F Piscaglia; P Chieco; B Cola; L Bolondi
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 3.  Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.

Authors:  Michael H Schiff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.

Authors:  Yoshinori Takashima; Shinya Hayashi; Koji Fukuda; Toshihisa Maeda; Masanori Tsubosaka; Tomoyuki Kamenaga; Kenichi Kikuchi; Masahiro Fujita; Yuichi Kuroda; Shingo Hashimoto; Naoki Nakano; Tomoyuki Matsumoto; Ryosuke Kuroda
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

Review 5.  Current and future management approaches for rheumatoid arthritis.

Authors:  Ferdinand C Breedveld
Journal:  Arthritis Res       Date:  2002-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.